| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.16 | 0.006 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.007 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.007 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.09 | 0.007 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.099 | 0.007 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.007 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.007 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.007 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.007 |